Company Predictive Technology Group, Inc. Other OTC
Equities
PRED
US74039H1023
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2019 | Weight | 2020 | Weight | Delta |
---|---|---|---|---|---|
Human Cell and Tissue Products
99.2
%
| 43 | 99.9 % | 24 | 99.2 % | -44.21% |
Diagnostics & Therapeutics
0.8
%
| 0 | 0.1 % | 0 | 0.8 % | +319.64% |
Sales per region
USD in Million | 2019 | Weight | 2020 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 43 | 100.0 % | 24 | 100.0 % | -43.80% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Bradley Robinson
CEO | Chief Executive Officer | 55 | 15-03-29 |
Rakesh Chettier
PRN | Corporate Officer/Principal | - | - |
Douglas Rabin
PRN | Corporate Officer/Principal | - | 19-06-03 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Bradley Robinson
CEO | Chief Executive Officer | 55 | 15-03-29 |
Chairman | 69 | 18-10-29 | |
Ronald Barhorst
BRD | Director/Board Member | 67 | 19-03-18 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 299,596,808 | 299,596,808 ( 100.00 %) | 0 | 100.00 % |
Company contact information
Predictive Technology Group, Inc.
615 Arapeen Drive Suite 300
84108, Salt Lake City
+
http://www.predtechgroup.comSector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-1.82% | 41.35B | |
+44.25% | 40.38B | |
+2.56% | 39.05B | |
-12.11% | 26.67B | |
+3.09% | 24.07B | |
-24.16% | 18.36B | |
+22.12% | 11.6B | |
-3.74% | 11.68B | |
+7.75% | 11.15B |